Heidelberg Pharma AG

Director's Dealing • Dec 18, 2023

News Details

Directors’ Dealings | 18 December 2023 11:20

Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

18.12.2023 / 11:20 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:	Prof. Dr.
First name:	Andreas
Last name(s):	Pahl

2. Reason for the notification

a) Position / status

Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A11QVV0

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
3.3800 EUR	676.00 EUR
3.3700 EUR	3,370.00 EUR
3.3800 EUR	3,042.00 EUR
3.3800 EUR	1,183.00 EUR
3.3800 EUR	1,859.00 EUR

d) Aggregated information

Price	Aggregated volume
3.3767 EUR	10,130.0000 EUR

e) Date of the transaction

2023-12-15; UTC+1

f) Place of the transaction

Name:	Xetra
MIC:	XETR

---

18.12.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	Heidelberg Pharma AG
	Gregor-Mendel-Str. 22
	68526 Ladenburg
	Germany
Internet:	www.heidelberg-pharma.com

End of News	EQS News Service